Patent: 9,878,984
✉ Email this page to a colleague
Summary for Patent: 9,878,984
Title: | Anti-cancer compounds |
Abstract: | The present invention relates to anti-cancer compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides analogs of the known anti-cancer compound amonafide, and structurally and functionally related compounds, and methods of using such compounds as therapeutic agents to treat a number of conditions associated with hyperproliferation. |
Inventor(s): | Huang; Sui (Chicago, IL), Norton; John (San Diego, CA), Appella; Daniel (Rockville, MD), Witschi; Mark (Davis, CA) |
Assignee: | NORTHWESTERN UNIVERSITY (Evanston, IL) |
Application Number: | 14/480,235 |
Patent Claims: | see list of patent claims |
Details for Patent 9,878,984
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2028-01-11 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2028-01-11 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2028-01-11 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |